Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Intangibles (2016 - 2025)

BioRestorative Therapies (BRTX) has disclosed Intangibles for 15 consecutive years, with $556634.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Intangibles fell 13.88% year-over-year to $556634.0, compared with a TTM value of $556634.0 through Sep 2025, down 13.88%, and an annual FY2024 reading of $623945.0, down 12.58% over the prior year.
  • Intangibles was $556634.0 for Q3 2025 at BioRestorative Therapies, down from $579071.0 in the prior quarter.
  • Across five years, Intangibles topped out at $803438.0 in Q4 2022 and bottomed at $550703.0 in Q2 2022.
  • Average Intangibles over 5 years is $657758.4, with a median of $645636.0 recorded in 2021.
  • The sharpest move saw Intangibles surged 37.74% in 2023, then decreased 13.88% in 2025.
  • Year by year, Intangibles stood at $589740.0 in 2021, then skyrocketed by 36.24% to $803438.0 in 2022, then dropped by 11.17% to $713692.0 in 2023, then dropped by 12.58% to $623945.0 in 2024, then fell by 10.79% to $556634.0 in 2025.
  • Business Quant data shows Intangibles for BRTX at $556634.0 in Q3 2025, $579071.0 in Q2 2025, and $601508.0 in Q1 2025.